SalMar (SALM) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
25 Aug, 2026Executive summary
Achieved record-high Q2 harvest volume of 81,800 tons, driven by strong biological performance in Norway and improved profitability in Sales & Industry, with successful completion of Ocean Farm 1 harvest.
Volume guidance for FY 2026 increased to 350,000 tons due to strong performance in Norway.
Agreement to acquire 70% of Måsøval for NOK 3.4 billion, strengthening position in core production areas and enabling significant synergies.
Operational EBIT for Q2 2026 was NOK 1,237 million, more than doubling YoY.
Profit for the period was NOK 367 million, compared to NOK 146 million in the same quarter last year.
Financial highlights
Operating revenues reached NOK 7,612 million in Q2 2026, up 17% QoQ and 24% YoY for H1 2026.
Operational EBITDA was NOK 1,769 million, up from NOK 994 million YoY.
Adjusted EPS for Q2 2026 was NOK 3.9, up from NOK 1.89 in Q2 2025.
Dividend of NOK 10 per share approved in June, totaling approximately NOK 1.3 billion paid in July 2026.
Cash flow from operating activities was NOK 2,121 million, up from NOK 1,318 million YoY.
Outlook and guidance
FY 2026 volume guidance raised to 350,000 tons, with Norway at 302,000–307,000 tons, Iceland at 21,000 tons, UK/Scotland at 43,000 tons, and SalMar Ocean at 5,100 tons.
Expect lower cost level and significantly higher volume in Q3 2026.
Continued strong demand anticipated, with low global supply growth in 2026.
Latest events from SalMar
- Record Q2 harvest, raised 2026 guidance, and Måsøval acquisition drive strong growth.SALM
Q2 2026 - Operational EBIT up 90% year-over-year; 2026 volume guidance raised to 330,000 tons.SALM
Q1 2026 - Operational EBIT surged 89% year-over-year, with higher harvest volumes and improved margins.SALM
Q1 2026 - Record harvests and improved Q4 profits set a positive outlook for 2026.SALM
Q4 2025 - Record Q4 harvests, strong operational gains, and NOK 10.00 dividend proposal set a positive 2026 outlook.SALM
Q4 2025 - Q3 EBIT was NOK 1,041m; 2024 guidance cut, but 2025 signals recovery and growth.SALM
Q3 2024 - Lower EBIT and revenues amid biological and regulatory headwinds; strong Central Norway and growth focus.SALM
Q2 2024 - Q2 EBIT and profit fell on lower prices, but guidance and growth initiatives remain strong.SALM
Q2 2024 - Q4 improved after a tough 2024; NOK 22 dividend, strong liquidity, and growth investments planned.SALM
Q4 2024